Literature DB >> 10655395

Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.

D O Sordelli1, F R Buzzola, M I Gomez, L Steele-Moore, D Berg, E Gentilini, M Catalano, A J Reitz, T Tollersrud, G Denamiel, P Jeric, J C Lee.   

Abstract

Staphylococcus aureus is an important cause of bovine mastitis worldwide, and effective preventive or therapeutic modalities are lacking. Although most human S. aureus isolates produce capsular polysaccharides (CPs), few reports have described the prevalence of capsules on bovine isolates. This information is important for the rational design of a vaccine for the prevention of staphylococcal mastitis. We serotyped 195 S. aureus strains isolated between 1989 and 1997 from the milk of mastitic cows in Argentina. Only 14 (7.1%) of the strains were serotype 5, and all were recovered between 1989 and 1992. Thirteen serotype 8 strains were identified, and 12 of these were isolated between 1991 and 1994. The remaining 168 isolates were nonreactive (NR) with CP serotype 5 (CP5)- or CP8-specific antibodies. Hybridization studies performed with genomic DNA from eight NR strains revealed that only three of them carried the capsule genes. Pulsed-field gel electrophoresis (PFGE) performed with 127 of the 195 S. aureus isolates revealed that most (86%) strains belonged to one of four major PFGE groups. Although 8 of 14 CP5 isolates showed a common PFGE pattern (arbitrarily defined as A1), 31 other A1 isolates from the same time period (1989 to 1992) were not CP5 positive. In contrast, only nine PFGE type B3 isolates were recovered between 1990 and 1994, and eight of these were positive for CP8 (P < 0.0003). The results of this study underscore the variability in capsule expression by S. aureus strains isolated from different geographical regions and cast doubt on the roles of CP5 and CP8 in the pathogenesis and immunoprophylaxis of bovine mastitis in Argentina.

Entities:  

Mesh:

Year:  2000        PMID: 10655395      PMCID: PMC86219     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Comparison of type A enterotoxigenic Staphylococcus aureus strains isolated from geographically far distant locations by pulsed field gel electrophoresis.

Authors:  H Y Tsen; G K Yu; H H Hu
Journal:  J Appl Microbiol       Date:  1997-04       Impact factor: 3.772

2.  The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes.

Authors:  Subrata Sau; Navneet Bhasin; Elisabeth R Wann; Jean C Lee; Timothy J Foster; Chia Y Lee
Journal:  Microbiology (Reading)       Date:  1997-07       Impact factor: 2.777

3.  Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis.

Authors:  A Guidry; A Fattom; A Patel; C O'Brien; S Shepherd; J Lohuis
Journal:  Am J Vet Res       Date:  1998-12       Impact factor: 1.156

4.  Genetic analysis of the cap5 locus of Staphylococcus aureus.

Authors:  E R Wann; B Dassy; J M Fournier; T J Foster
Journal:  FEMS Microbiol Lett       Date:  1999-01-01       Impact factor: 2.742

5.  Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8.

Authors:  B Poutrel; C Mendolia; L Sutra; J M Fournier
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Field trials of a vaccine against bovine mastitis. 1. Evaluation in heifers.

Authors:  J A Giraudo; A Calzolari; H Rampone; A Rampone; A T Giraudo; C Bogni; A Larriestra; R Nagel
Journal:  J Dairy Sci       Date:  1997-05       Impact factor: 4.034

7.  Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.

Authors:  D McKenney; K L Pouliot; Y Wang; V Murthy; M Ulrich; G Döring; J C Lee; D A Goldmann; G B Pier
Journal:  Science       Date:  1999-05-28       Impact factor: 47.728

8.  Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.

Authors:  J C Lee; M J Liu; J Parsonnet; R D Arbeit
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.

Authors:  M Thakker; J S Park; V Carey; J C Lee
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.

Authors:  A I Fattom; J Sarwar; L Basham; S Ennifar; R Naso
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more
  23 in total

1.  Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA.

Authors:  Thanh Luong; Subrata Sau; Marisa Gomez; Jean C Lee; Chia Y Lee
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Multicenter study on spreading of the tet(M) gene in tetracycline-resistant Streptococcus group G and C isolates in Argentina.

Authors:  P E Jeric; H Lopardo; P Vidal; S Arduino; A Fernandez; B E Orman; D O Sordelli; D Centrón
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy.

Authors:  Tom Grunert; Mareike Wenning; María Sol Barbagelata; Martina Fricker; Daniel O Sordelli; Fernanda R Buzzola; Monika Ehling-Schulz
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

4.  Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.

Authors:  Lorena P N Tuchscherr; Fernanda R Buzzola; Lucía P Alvarez; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

5.  Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice.

Authors:  Lorena P N Tuchscherr; Fernanda R Buzzola; Lucía P Alvarez; Roberto L Caccuri; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Comparison of Staphylococcus aureus isolates from bovine and human skin, milking equipment, and bovine milk by phage typing, pulsed-field gel electrophoresis, and binary typing.

Authors:  R N Zadoks; W B van Leeuwen; D Kreft; L K Fox; H W Barkema; Y H Schukken; A van Belkum
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Differential abilities of capsulated and noncapsulated Staphylococcus aureus isolates from diverse agr groups to invade mammary epithelial cells.

Authors:  Fernanda R Buzzola; Lucía P Alvarez; Lorena P N Tuchscherr; María S Barbagelata; Santiago M Lattar; Luis Calvinho; Daniel O Sordelli
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

8.  Survey of potential factors involved in the low frequency of CP5 and CP8 expression in Staphylococcus aureus isolates from mastitis of dairy cattle from Argentina, Chile, and Uruguay.

Authors:  Maria Belen Ambroggio; Melina Soledad Perrig; Cecilia Camussone; Nazarena Pujato; Alicia Bertón; Edgardo Gianneechini; Silvia Alvarez; Ivan Sergio Marcipar; Luis Fernando Calvinho; Maria Sol Barbagelata
Journal:  J Appl Genet       Date:  2018-05-03       Impact factor: 3.240

9.  Capsule expression and genotypic differences among Staphylococcus aureus isolates from patients with chronic or acute osteomyelitis.

Authors:  Santiago M Lattar; Lorena P N Tuchscherr; Roberto L Caccuri; Daniela Centrón; Karsten Becker; Claudio A Alonso; Claudia Barberis; Graciela Miranda; Fernanda R Buzzola; Christof von Eiff; Daniel O Sordelli
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

Review 10.  Staphylococcus aureus capsular polysaccharides.

Authors:  Katherine O'Riordan; Jean C Lee
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.